Early detection and treatment Archives

Ita Buttrose with text saying: Ita's plea

Ita’s coronavirus plea

July 10, 2020
Michelle Hauschild

Australian icon Ita Buttrose has issued a passionate plea to senior Australians in a bid to avoid thousands of people going unnecessarily blind during the COVID-19 pandemic.

Ita’s plea to older Australians

May 7, 2020
Michelle Hauschild

Australian icon Ita Buttrose has issued a passionate plea to senior Australians during the COVID-19 pandemic.

Risk of increased blindness in COVID confusion

April 3, 2020
Michelle Hauschild

Australia is facing a massive increase in the number of people who could unnecessarily lose their sight due to treatment cancellations caused by fear and confusion around COVID-19.

COVID-19 announcement

March 27, 2020
Michelle Hauschild

With the spread COVID-19, there’s a lot of new health information to understand. What’s the impact on the macular disease community?

AMD: Know your family risk

May 20, 2019
Michelle Hauschild

If you’re looking for the classic case study on how age-related macular degeneration (AMD) runs in families, the Walker / Russell family is – unfortunately – it.

The hereditary risk of AMD

May 6, 2019
admin

She’s only 22, but already Jessica Falon is making the changes necessary to try to prevent the macular disease that has blinded her grandmother.

Are you next in line for AMD?

May 5, 2019
Michelle Hauschild

More than 60% of Australians are unaware of the strong familial risks associated with Australia’s leading cause of blindness.

Patient voices: Elisabeth

March 23, 2019
Michelle Hauschild

Hear directly from Elisabeth – a member of our community – on her journey with wet AMD.

Anti-VEGF treatment not linked to stroke

February 2, 2019
Michelle Hauschild

Anti-VEGF therapy is not linked to an increased risk of stroke, myocardial infarction or death, according to a new report.

Interest: Early detection and treatment

Ita’s coronavirus plea

Ita’s plea to older Australians

Risk of increased blindness in COVID confusion

COVID-19 announcement

Patient voices: Elisabeth

Anti-VEGF treatment not linked to stroke

Follow us

Newsletter sign-up

Thank you.
Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

Interest: Early detection and treatment

Follow us

Newsletter sign-up

Thank you.Your contact form has been successfully submitted.

Unfortunately there are no matches for your search.

Please try another search term.

Thank you for your order!

Your pack will be sent in the next two business days.

Your expression of interest in our research grants program has been submitted.

We will be in touch at the next stage of the process.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for referring to MDFA for non-clinical support and macular disease information. We will be in contact in 2-3 business days.

Thank you for subscribing to MDFA’s newsletter/s.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about MDFA’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for subscribing to our newsletter.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.Tell people about Macular Disease Foundation’s newsletters:

Thank you for registering for this event.

Let people know you're attending:

The is for health professionals only. Please enter your organisation and practitioner type to subscribe. If you are not a health professional, please untick this newsletter to continue.

Thank you.
Your contact form has been successfully submitted.

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about MDFA’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters:

You can opt-out at any time by contacting us on [email protected] or via our National Helpline: 1800 111 709.

Tell people about Macular Disease Foundation’s newsletters: